Imtakt USA
Our HPLC columns have been designed and manufactured by Imtakt Corporation with exceptional craftsmanship and decades of industry experience.
Company Description
Our HPLC columns have been designed and manufactured by Imtakt Corporation with exceptional craftsmanship and decades of industry experience. Our columns give chromatographers:
- High resolution
- 25–50% lower pressure
- Novel chemistry
Chief Chromatographic Techniques Supported
- High performance liquid chromatography
- Liquid chromatography–mass spectrometry
- Reverse phase
- Normal phase
- Anion exchange
- Cation exchange
- Multi-mode
- Small molecule separations
- Protein separations
Markets Served
All LC and LC–MS markets including: pharmaceutical, biotech, contract research, forensic, clinical diagnostic, food and beverage, industrial, chemical, environmental, and academic research.
Major Products/Services
Below is a sample of some HPLC column phases from Imtakt:
- SCHERZO SM-C18: multi-mode including anion exchange, cation exchange, reverse phase, and normal phase.
- PRESTO FF-C18: consists of C18 bonded to monodispersed 2 µm nonporous silica. It is useful for both biopolymer and synthetic polymer separations.
- CADENZA CD-C18: high resolution; 25–50% lower pressure; best with hydrophobic compounds, molecular recognition, and multicompenant separation.
- UNISON UK-C18: best with polar compounds, separation balance, no phase collapse with 100% aqueous eluent.
- UNISON UK-AMINO: revolutionary aqueous durability for aminopropyl phase; aqueous to nonaqueous normal phase separation.
Facilities
We are located in Philadelphia, Pennsylvania and deliver next day for 95% of North American orders and always within one week.
Imtakt USA
1511 Walnut Street, Suite 310
Philadelphia, PA 19102
TELEPHONE
(215) 665-8902
FAX
(501) 646-3497
WEB SITE
YEAR FOUNDED
2004
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
